Concise Review: Endothelial Progenitor Cells in Regenerative Medicine: Applications and Challenges.

PubWeight™: 0.80‹?›

🔗 View Article (PMID 26956207)

Published in Stem Cells Transl Med on March 08, 2016

Authors

Mark Seow Khoon Chong1, Wei Kai Ng1, Jerry Kok Yen Chan2

Author Affiliations

1: School of Chemical and Biochemical Engineering, Nanyang Technological University, Singapore.
2: Department of Reproductive Medicine, KK Women's and Children's Hospital, Singapore Cancer and Stem Cell Biology, Duke-NUS Graduate Medical School, Singapore Department of Obstetrics and Gynaecology, National University of Singapore, Singapore jerrychan@nus.edu.sg.

Associated clinical trials:

Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent (REMEDEE) | NCT00967902

Articles cited by this

Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27

Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med (2003) 13.84

Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med (1999) 10.16

Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood (2000) 9.24

Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation (2003) 7.29

Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood (2004) 7.21

Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A (2000) 6.59

Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol (2003) 4.35

Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial. JAMA (2011) 4.09

Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res (2011) 3.72

Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation (2005) 3.54

Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp Hematol (2007) 3.42

In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood (2007) 3.24

Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation (2007) 2.88

Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res (2012) 2.78

Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood (2004) 2.76

Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation (2003) 2.52

Proteomic analysis reveals presence of platelet microparticles in endothelial progenitor cell cultures. Blood (2009) 2.40

Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol (2007) 2.23

Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential. Arterioscler Thromb Vasc Biol (2008) 2.16

Flow cytometric identification and functional characterization of immature and mature circulating endothelial cells. Arterioscler Thromb Vasc Biol (2012) 2.07

Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood (2009) 2.00

Concise review: Circulating endothelial progenitor cells for vascular medicine. Stem Cells (2011) 1.80

Therapeutic potential of vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells for functional bone healing. Am J Pathol (2006) 1.75

Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities. BMC Med Genomics (2010) 1.60

Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis (2009) 1.57

Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial. Circulation (2015) 1.55

Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Catheter Cardiovasc Interv (2011) 1.47

Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor. Diabetes (2015) 1.47

Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial. Circ Res (2015) 1.44

Methodological development of a clonogenic assay to determine endothelial progenitor cell potential. Circ Res (2011) 1.43

A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res (2004) 1.32

Endothelial progenitor cell: a blood cell by many other names may serve similar functions. J Mol Med (Berl) (2013) 1.16

Mobilization of endothelial progenitor cells in fracture healing and distraction osteogenesis. Bone (2008) 1.10

Circulating and tissue resident endothelial progenitor cells. J Cell Physiol (2014) 1.07

Angiotensin-converting enzyme 2 priming enhances the function of endothelial progenitor cells and their therapeutic efficacy. Hypertension (2012) 1.05

Isolating and defining cells to engineer human blood vessels. Cell Prolif (2011) 1.03

Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. J Vasc Surg (2009) 1.02

Differential roles of angiogenic chemokines in endothelial progenitor cell-induced angiogenesis. Basic Res Cardiol (2012) 0.99

Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus. Am Heart J (2006) 0.99

Functional endothelial progenitor cells from cryopreserved umbilical cord blood. Cell Transplant (2010) 0.97

Prospective randomised trial evaluating a paclitaxel-coated balloon in patients treated with endothelial progenitor cell capturing stents for de novo coronary artery disease. Heart (2011) 0.96

Intracoronary autologous CD34+ stem cell therapy for intractable angina. Cardiology (2010) 0.96

Efficient nonadhesive ex vivo expansion of early endothelial progenitor cells derived from CD34+ human cord blood fraction for effective therapeutic vascularization. FASEB J (2010) 0.96

Circulating CD34+ cell subsets in patients with coronary endothelial dysfunction. Nat Clin Pract Cardiovasc Med (2008) 0.96

Development of a novel prohealing stent designed to deliver sirolimus from a biodegradable abluminal matrix. Circ Cardiovasc Interv (2010) 0.95

CD34 hybrid cells promote endothelial colony-forming cell bioactivity and therapeutic potential for ischemic diseases. Arterioscler Thromb Vasc Biol (2013) 0.93

Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood. Clin Exp Pharmacol Physiol (2007) 0.92

Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into early endothelial progenitor cells reveals highly differential gene expression. PLoS One (2011) 0.92

Induction of erythropoiesis using human vascular networks genetically engineered for controlled erythropoietin release. Blood (2011) 0.92

Differential effects of nebivolol and metoprolol on arterial stiffness, circulating progenitor cells, and oxidative stress. J Am Soc Hypertens (2014) 0.91

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis (2011) 0.91

CD34+ cells augment endothelial cell differentiation of CD14+ endothelial progenitor cells in vitro. J Cell Mol Med (2008) 0.91

Strategies to Stimulate Mobilization and Homing of Endogenous Stem and Progenitor Cells for Bone Tissue Repair. Front Bioeng Biotechnol (2015) 0.90

Progenitors in motion: mechanisms of mobilization of endothelial progenitor cells. Br J Clin Pharmacol (2009) 0.89

Specific role of impaired glucose metabolism and diabetes mellitus in endothelial progenitor cell characteristics and function. Arterioscler Thromb Vasc Biol (2014) 0.89

Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials (2012) 0.89

Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. Atherosclerosis (2012) 0.88

Development of serum-free quality and quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. Stem Cells Transl Med (2012) 0.88

Ex vivo expansion of human outgrowth endothelial cells leads to IL-8-mediated replicative senescence and impaired vasoreparative function. Stem Cells (2013) 0.87

Endothelial outgrowth cells: function and performance in vascular grafts. Tissue Eng Part B Rev (2013) 0.87

Cilostazol enhances mobilization and proliferation of endothelial progenitor cells and collateral formation by modifying vasculo-angiogenic biomarkers in peripheral arterial disease. Int J Cardiol (2014) 0.87

Contrasting effects of vasculogenic induction upon biaxial bioreactor stimulation of mesenchymal stem cells and endothelial progenitor cells cocultures in three-dimensional scaffolds under in vitro and in vivo paradigms for vascularized bone tissue engineering. Tissue Eng Part A (2012) 0.87

A direct comparison of endothelial progenitor cell dysfunction in rat metabolic syndrome and diabetes. Atherosclerosis (2012) 0.86

Effects of physical activity on endothelial progenitor cells (EPCs). Front Physiol (2014) 0.86

Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients. Atherosclerosis (2014) 0.86

The CD133+ cell as advanced medicinal product for myocardial and limb ischemia. Stem Cells Dev (2014) 0.86

Development of cell-selective films for layered co-culturing of vascular progenitor cells. Biomaterials (2009) 0.86

Capture of flowing endothelial cells using surface-immobilized anti-kinase insert domain receptor antibody. Tissue Eng Part C Methods (2008) 0.85

Endothelial progenitor cell capture stent: safety and effectiveness. J Interv Cardiol (2012) 0.85

Vasculogenic and osteogenesis-enhancing potential of human umbilical cord blood endothelial colony-forming cells. Stem Cells (2012) 0.84

Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev (2012) 0.84

G-CSF induced arteriogenesis in humans: molecular insights into a randomized controlled trial. Curr Vasc Pharmacol (2013) 0.84

Autologous stem cells for the treatment of post-mastectomy lymphedema: a pilot study. Cytotherapy (2011) 0.84

Prospective surface marker-based isolation and expansion of fetal endothelial colony-forming cells from human term placenta. Stem Cells Transl Med (2013) 0.81

The effects of external counter pulsation therapy on circulating endothelial progenitor cells in patients with angina pectoris. Cardiology (2007) 0.81

Beyond cell capture: antibody conjugation improves hemocompatibility for vascular tissue engineering applications. Tissue Eng Part A (2010) 0.80

Magnetic-based multi-layer microparticles for endothelial progenitor cell isolation, enrichment, and detachment. Biomaterials (2013) 0.80

Accelerating in situ endothelialisation of cardiovascular bypass grafts. Int J Mol Sci (2014) 0.79

Endothelial progenitor cells accelerate the resolution of deep vein thrombosis. Vascul Pharmacol (2015) 0.79

Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential. Angiogenesis (2013) 0.79

Introduction to next generation of endothelial progenitor cell therapy: a promise in vascular medicine. Am J Transl Res (2015) 0.79

Critical assessment of putative endothelial progenitor phenotypes. Exp Hematol (2007) 0.78

Autologous bone marrow mononuclear cell implantation therapy is an effective limb salvage strategy for patients with severe peripheral arterial disease. J Vasc Surg (2015) 0.77

Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial). Minerva Cardioangiol (2013) 0.77

Interleukin-10 overexpression improves the function of endothelial progenitor cells stimulated with TNF-α through the activation of the STAT3 signaling pathway. Int J Mol Med (2014) 0.77

Endothelial progenitor cell-based therapy for pulmonary arterial hypertension. Cell Transplant (2013) 0.77

A novel and simplified method of culture of human blood-derived early endothelial progenitor cells for the treatment of ischemic vascular disease. Cell Transplant (2011) 0.77

Construction of an Aptamer-SiRNA Chimera-Modified Tissue-Engineered Blood Vessel for Cell-Type-Specific Capture and Delivery. ACS Nano (2015) 0.76

Enhancing endothelial progenitor cell for clinical use. World J Stem Cells (2015) 0.76

Endothelial progenitor cells in diabetic patients with myocardial infarction - can statins improve their function? Eur J Pharmacol (2014) 0.76

Autologous immuno magnetically selected CD133+ stem cells in the treatment of no-option critical limb ischemia: clinical and contrast enhanced ultrasound assessed results in eight patients. J Transl Med (2015) 0.76

Effect of Vitamins C and E on Endothelial Function in Type 1 Diabetes Mellitus. J Diabetes Res (2015) 0.76